Physician profile
Majdi Ashchi
NPI 1134118805
$25,808.98
in general payments reported to CMS, 2019-2025
69 companies · $3,238 in 2025
The $3,238 reported for 2025 was more than what 89% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,609 · 2020: $1,988 · 2021: $4,260 · 2022: $3,695 · 2023: $5,229 · 2024: $3,790 · 2025: $3,238.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Education: $815 · Travel and Lodging: $176 · Consulting Fee: $10.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,255.69 |
| Education | $815.00 |
| Travel and Lodging | $175.90 |
| Consulting Fee | $10.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $2,083.93 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Medtronic, INC. | $1,966.46 | 2021-2025 | Abre, Venaseal, Onyx Frontier |
| Abiomed | $1,624.29 | 2019-2025 | Impella |
| Boston Scientific Corporation | $1,523.10 | 2019-2025 | Watchman Flx, Varithena Administration Pack, Acuity Steerable |
| Cms Imaging, INC. | $1,411.50 | 2021-2025 | |
| Angiodynamics, INC. | $1,396.53 | 2019-2023 | Venacure 1470 Pro, Alphavac, Venacure 1470 Pro |
| Abbott Laboratories | $1,329.71 | 2019-2025 | Cardiomems, Mitraclip, Diamondback Peripheral |
| Amgen INC. | $1,250.85 | 2019-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $831.97 | 2019-2025 | Farxiga, Lokelma |
| Philips North America LLC | $762.49 | 2019-2025 | (Dd3) Venous Stent Und, (Ck7) Extended Holter, Extended Holter |
| Janssen Pharmaceuticals, INC | $709.80 | 2019-2024 | Xarelto |
| Cook Medical LLC | $689.07 | 2021-2024 | Zilver Ptx |
| Bard Peripheral Vascular, INC. | $679.22 | 2021-2024 | Venclose Maven Catheter |
| Novartis Pharmaceuticals Corporation | $568.85 | 2019-2025 | |
| Pfizer INC. | $515.73 | 2019-2025 |
Show all 68 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $501.46 | 2021-2025 | Barostim Neo System |
| Sanofi-Aventis U.S. LLC | $495.38 | 2019-2023 | |
| Cardiovascular Systems INC. | $490.69 | 2019-2023 | |
| Bardy Diagnostics, INC. | $478.50 | 2020-2022 | |
| Alnylam Pharmaceuticals INC. | $475.19 | 2021-2024 | Onpattro |
| Stryker Corporation | $474.39 | 2025 | Limflow System, Flowtriever, Ct Thrombectomy System Kit |
| Impulse Dynamics (USA) INC. | $442.54 | 2021-2023 | Optimizer |
| Baxter Healthcare | $402.97 | 2023-2025 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Boehringer Ingelheim Pharmaceuticals, INC. | $338.38 | 2019-2025 | Jardiance |
| Amarin Pharma, INC. | $335.19 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $275.48 | 2021-2025 | Verquvo |
| Contego Medical, INC | $268.52 | 2024-2025 | |
| Edwards Lifesciences Corporation | $267.88 | 2021-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| E.R. Squibb & Sons, L.L.C. | $266.99 | 2019-2024 | Eliquis, Camzyos |
| Shockwave Medical, INC | $260.18 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Opsens INC. | $239.12 | 2019-2020 | |
| Terumo Medical Corporation | $201.49 | 2021-2024 | Glidewire, Glidesheath Slender, Navicross |
| Venclose INC. | $171.03 | 2020 | |
| Esperion Therapeutics, INC. | $170.92 | 2020 | |
| Imperative Care, INC | $157.45 | 2024-2025 | Prodigy Catheter, Symphony Catheter |
| United Therapeutics Corporation | $143.34 | 2020 | |
| Cardinal Health 200 LLC | $137.23 | 2019-2020 | |
| Heartflow, INC. | $124.23 | 2023 | Ffrct |
| Akcea Therapeutics, INC. | $119.24 | 2021 | |
| Siemens Medical Solutions USA, INC. | $115.41 | 2020-2022 | |
| Medtronic Vascular, INC. | $110.58 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $109.43 | 2019-2025 | Lifevest |
| Actelion Pharmaceuticals US, INC. | $101.69 | 2019-2022 | |
| Asahi Intecc USA, INC. | $100.00 | 2021 | |
| Biosense Webster, INC. | $75.65 | 2019 | |
| Scpharmaceuticals INC. | $74.97 | 2023-2024 | |
| Cashflow Solutions, LLC | $66.60 | 2023-2025 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Avinger INC. | $61.36 | 2021-2022 | |
| Tactile Systems Technology INC | $48.10 | 2020-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Biotronik INC. | $41.86 | 2019-2020 | |
| Bridgebio Pharma, INC. | $30.49 | 2025 | Attruby |
| Celgene Corporation | $22.36 | 2025 | |
| Reflow Medical INC | $22.10 | 2023 | |
| Astellas Pharma US INC | $21.98 | 2019 | |
| Genzyme Corporation | $21.76 | 2022 | |
| Coloplast Corp | $20.63 | 2025 | |
| W. L. Gore & Associates, INC. | $20.07 | 2025 | Gore Cardioform Septal Occluder |
| Bayer Healthcare Pharmaceuticals INC. | $19.57 | 2022 | |
| Ionis Pharmaceuticals, INC. | $17.30 | 2025 | Tryngolza |
| Kiniksa Pharmaceuticals International, Plc | $16.91 | 2024 | Arcalyst |
| Jazz Pharmaceuticals INC. | $16.66 | 2021 | |
| Atricure, INC. | $14.84 | 2021 | |
| Organogenesis INC. | $14.24 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $14.03 | 2019 | |
| Cleerly, INC. | $14.03 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Inspire Medical Systems, INC. | $13.61 | 2023 | Inspire |
| Penumbra, INC. | $10.74 | 2021 | |
| Coala Life INC | $10.72 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Majdi Ashchi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.